Lice are parasites that grow mostly in the head or pubic areas and feed on human blood. These parasites are increasingly becoming resistant to traditional methods of treatments which has created an urgent need for the development of effective treatment options.
Lice Treatment Market Size is projected to grow USD 0.2 billion by 2032, at CAGR 6.6 % during the forecast period
The prevalence of lice parasites contamination is increasing perpetually worldwide which is the prime factor boosting the growth of the lice treatment market. New product launches, elevation in level of awareness, and easy availability of lice treatment products is fueling the growth of the market. Growing R&D activities by pharmaceutical companies to come up effective compounds which can effective kill these more than ever resistant parasites is likely to provide attractive opportunities to the market.
They don't transmit infections like head lice are well-known for doing. There is, nevertheless, the risk of extreme itching and the development of secondary skin conditions. Head lice may cause sleeplessness, intense itching, discomfort, and a lack of concentration on the most important aspects of life. As a result, the global lice treatment market is expanding at a rapid pace. Manufacturers have made products like pyrethrin and lotions like benzyl alcohol lotions widely available to keep up with demand. Several nations in the Americas, such as the United States, are seeing an increase in vulnerable children, fueling the market.
The epidemic has impacted a wide range of industries and businesses, including some critical medical sectors. It also had a negative influence on the market's expansion. The protracted lockdown in several nations has resulted in the dissolution of public meetings and the closing of academic institutions. Lice infestations have been on the decline in recent years due to such reasons. The need for lice treatment decreased dramatically during the epidemic since it was no longer considered a requirement.
Major Key Players:
Some of the Key Market Players are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others
Segment Analysis
The Global Lice Treatment Market Insights is segmented based on type, treatment, end user, and region Based on type, the market is segmented into pediculosis capitis, pediculosis corporis, and pubic lice treatment. On the basis of treatment, the market is divided into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is bifurcated into permethrin, pyrethrin, and others. The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By distribution channel, the market is segmented into hospitals & clinics, retail pharmacies, and online platform. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.
Regional Analysis
The Americas leads the global lice treatment market. This can be attributed due to growing child population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth. In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global lice treatment market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
